Evidence map›Paper›PMID 42422076›Full record

ReviewFrontiers in pharmacology2026

Arctigenin as a promising anticancer agent: a comprehensive review of molecular mechanisms across major carcinomas.

Deena Elsori, Pratibha Pandey, Mohammad Abohassan, Mohd Saeed, Nida Khan, Sorabh Lakhanpal, Meenakshi Verma, Anuj Kumar Rana, Fahad Khan

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Deena ElsoriFaculty of Resilience, Rabdan Academy, Abu Dhabi, United Arab Emirates.
Pratibha PandeyUniversity Centre for Research and Development, Chandigarh University, Mohali, Punjab, India.
Mohammad AbohassanDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi Arabia.
Mohd SaeedDepartment of Biology, College of Science, University of Hail, Hail, Saudi Arabia.
Nida KhanDepartment of General Medicine, Faculty of Medicine and Health Sciences, Integral Institute of Medical Sciences & Research, Integral University, Lucknow, India.
Sorabh LakhanpalSchool of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, India.
Meenakshi VermaUniversity Centre for Research and Development, Chandigarh University, Mohali, Punjab, India.
Anuj Kumar RanaSchool of Applied and Life Sciences, Uttaranchal University, Dehradun, India.
Fahad KhanDepartment of Community Medicine, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the presence of numerous efficacious bioactive compounds, the development of effective cancer therapies remains necessary. Thus, the exploitation of the medicinal potential of bioactive compounds in cancer management has become an urgent demand. Arctigenin (AG), a natural lignin derived from

Indexed as

anticancerarctigeninbioavailabilitylignanphytochemical

Identifiers

PMID42422076
PMCPMC13341301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.